{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-010747","form_type":"8-K","ticker":null,"cik":"0000876378","company_name":"ASENSUS SURGICAL, INC.","filed_at":"2024-04-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.250641+00:00","generated_at":"2026-06-04T03:11:13.531608+00:00","sec_items":["1.01","2.03","3.03","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Asensus Surgical receives non-binding acquisition proposal from KARL STORZ at $0.35/share, plus $20M bridge loan","bullets":["KARL STORZ proposes to acquire all shares for $0.35/share cash, representing 66.7% premium to April 2 close.","Exclusive negotiations for up to 10 weeks; KARL STORZ provides up to $20M secured bridge loan to fund operations.","Bridge loan provides up to $10M during exclusivity period, additional $10M after definitive merger agreement signed.","No assurance deal will close; requires due diligence, definitive agreement, Board and stockholder approval.","Bridge loan has SOFR+10% interest rate, secured by all company assets including intellectual property."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-010747","json":"https://secwatch.observer/filing/0001437749-24-010747.json","markdown":"https://secwatch.observer/filing/0001437749-24-010747.md","text":"https://secwatch.observer/filing/0001437749-24-010747.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/876378/000143774924010747/0001437749-24-010747-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/876378/000143774924010747/asxc20240402_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T03:11:13.531608+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"97baea5e723c62f0543add0f9acf13a7a673fc79","claim":"ASENSUS SURGICAL, INC. incurred loan of up to $20 million with KARL STORZ SE & Co. KG at SOFR plus 10% maturing the earliest of (i) the date that is thirty days after the Company ceases discussions... (ii) the date that is sixty days after the lapse of the Exclusivity Per.","evidence_excerpt":"On April 3, 2024, Asensus Surgical, Inc. (the \"Company\") issued a promissory note in favor of KARL STORZ SE & Co. KG (\"KARL STORZ\") in the principal amount of up to $20 million (the \"Note\").","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/876378/000143774924010747/0001437749-24-010747-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"up to $20 million"},{"label":"Counterparty","value":"KARL STORZ SE & Co. KG"},{"label":"Rate","value":"SOFR plus 10%"},{"label":"Maturity","value":"the earliest of (i) the date that is thirty days after the Company ceases discussions... (ii) the date that is sixty days after the lapse of the Exclusivity Per"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"fd5c9d26904ebf7260d03fe2936aa7048d162bc6","claim":"ASENSUS SURGICAL, INC. entered into Note with KARL STORZ SE & Co. KG valued at up to $20 million (effective 2024-04-03).","evidence_excerpt":"On April 3, 2024, Asensus Surgical, Inc. (the “Company”) issued a promissory note in favor of KARL STORZ SE & Co. KG (“KARL STORZ”) in the principal amount of up to $20 million (the “Note”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/876378/000143774924010747/0001437749-24-010747-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"KARL STORZ SE & Co. KG"},{"label":"Value","value":"up to $20 million"},{"label":"Effective","value":"2024-04-03"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}